Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiagabine to Enhance Slow Wave Sleep in OSA
NCT02387710Phase 2Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Mar 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obstructive sleep apnea (OSA) comparing Tiagabine with Placebo (2 arms). Primary endpoint: Apnea Hypopnea Index. Started Mar 2015; status: completed.
02
Drugs
tiagabine
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT02387710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02387710.